Carregant...
Coverage For High Cost Specialty Drugs for Rheumatoid Arthritis in Medicare Part D
OBJECTIVE: One in four Medicare beneficiaries with rheumatoid arthritis (RA) use high cost biologic disease modifying drugs (DMARDs), and spending for these drugs has risen sharply for Medicare Part D. We conducted the first systematic, national investigation of how Part D plans cover biologic DMARD...
Guardat en:
| Publicat a: | Arthritis Rheumatol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4464809/ https://ncbi.nlm.nih.gov/pubmed/25900105 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39079 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|